Neonatal drug withdrawal.

Academic Article

Abstract

  • Maternal use of certain drugs during pregnancy can result in transient neonatal signs consistent with withdrawal or acute toxicity or cause sustained signs consistent with a lasting drug effect. In addition, hospitalized infants who are treated with opioids or benzodiazepines to provide analgesia or sedation may be at risk for manifesting signs of withdrawal. This statement updates information about the clinical presentation of infants exposed to intrauterine drugs and the therapeutic options for treatment of withdrawal and is expanded to include evidence-based approaches to the management of the hospitalized infant who requires weaning from analgesics or sedatives.
  • Authors

    Published In

  • Pediatrics  Journal
  • Keywords

  • Analgesics, Opioid, Benzodiazepines, Evidence-Based Medicine, Female, Humans, Hypnotics and Sedatives, Infant, Newborn, Neonatal Abstinence Syndrome, Pregnancy, Street Drugs, Substance Abuse Detection
  • Digital Object Identifier (doi)

    Author List

  • Hudak ML; Tan RC; COMMITTEE ON DRUGS; COMMITTEE ON FETUS AND NEWBORN; American Academy of Pediatrics
  • Start Page

  • e540
  • End Page

  • e560
  • Volume

  • 129
  • Issue

  • 2